SF
GSK icon

Summit Financial’s GSK GSK Stock Holding History

Summit Financial’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$839K Buy
15,858
+127
+0.8% +$6.72K 0.01% 899
2026
Q1 		$876K Buy
15,731
+8,166
+108% +$443K 0.01% 820
2025
Q4 		$374K Buy
7,565
+368
+5% +$17.2K 0.01% 990
2025
Q3 		$311K Sell
7,197
-528
-7% -$20.6K ﹤0.01% 1049
2025
Q2 		$300K Buy
7,725
+1,068
+16% +$40.8K 0.01% 680
2025
Q1 		$258K Sell
6,657
-471
-7% -$17.2K 0.01% 645
2024
Q4 		$244K Buy
7,128
+2,218
+45% +$79.8K 0.01% 581
2024
Q3 		$202K Buy
+4,910
New +$201K 0.01% 526

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Summit Financial's GSK Position: Q2 2026 in Review

Summit Financial increased its GSK (GSK) stake by 0.81% in Q2 2026, buying an estimated $6.72K and bringing the position to 15,858 shares worth $839K. The position accounts for 0.01% of the portfolio, ranked #899.

Summit Financial first reported a position in GSK in Q3 2024 and has held it in 8 quarters since. The position peaked at $876K in Q1 2026. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Summit Financial held 15,858 shares of GSK worth $839K as of Q2 2026.
  • Summit Financial bought 127 GSK shares in Q2 2026, an estimated $6.72K.
  • GSK made up 0.01% of Summit Financial's portfolio in Q2 2026, its #899 holding.
  • Summit Financial first reported a position in GSK in Q3 2024 and has held it in 8 quarters since.
  • Summit Financial's GSK position peaked at $876K in Q1 2026.
  • 1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Summit Financial's 13F filing for Q2 2026, filed 12 Aug 2026.